[(3S)-3-fluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]methylimino-iminoazanium
C11H20FN4O2+ — CID 123652062
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(3S)-3-fluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]methylimino-iminoazanium
[(3S)-3-fluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]methylimino-iminoazanium (PubChem CID 123652062) has the molecular formula C11H20FN4O2+ and a molecular weight of 259.30 g/mol. Its IUPAC name is [(3S)-3-fluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]methylimino-iminoazanium.
Molecular Properties
| Compound Name | [(3S)-3-fluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]methylimino-iminoazanium |
|---|---|
| PubChem CID | 123652062 |
| Molecular Formula | C11H20FN4O2+ |
| Molecular Weight | 259.30 g/mol |
| Exact Mass | 259.16 |
| IUPAC Name | [(3S)-3-fluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-3-yl]methylimino-iminoazanium |
| SMILES | CC(C)(C)OC(=O)N1CCC[C@@](F)(CN=[N+]=N)C1 |
| InChI | InChI=1S/C11H20FN4O2/c1-10(2,3)18-9(17)16-6-4-5-11(12,8-16)7-14-15-13/h13H,4-8H2,1-3H3/q+1/t11-/m1/s1 |
| InChIKey | BPRXLMTYFSQOKN-LLVKDONJSA-N |
| XLogP | 2.28 |
| TPSA | 79.85 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 18 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 259.30 |
| LogP ≤ 5 | 2.28 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_3', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123652062 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.